Abstract
For more than 30 years, lipid droplets (LDs) were considered as an inert bag of lipid for storage of energy-rich fat molecules. Following a paradigm shift almost a decade ago, LDs are presently considered an active subcellular organelle especially designed for assembling, storing and subsequently supplying lipids for generating energy and membrane synthesis (and in the case of hepatocytes for VLDL secretion). LDs also play a central role in many other cellular functions such as viral assembly and protein degradation. Here, we have explored the structural and functional changes that occur in hepatic and adipose tissue LDs following chronic ethanol consumption in relation to their role in the pathogenesis of alcoholic liver injury.
Keywords: Liver, alcohol, steatosis, lipid, triglycerides, adipose, lipid droplet, perilipin, phosphatidylcholine, phosphatidylethanolamine, lipases, ATGL, HSL, TGH, lipolysis, lipophagy, VLDL, rab, dynamin, Src, HCV, MiRs, betaine.
Current Molecular Pharmacology
Title:Structure, Function and Metabolism of Hepatic and Adipose Tissue Lipid Droplets: Implications in Alcoholic Liver Disease
Volume: 10
Author(s): Sathish Kumar Natarajan, Karuna Rasineni, Murali Ganesan, Dan Feng, Benita L. McVicker, Mark A. McNiven, Natalia A. Osna, Justin L. Mott, Carol A. Casey and Kusum K. Kharbanda*
Affiliation:
- Veterans Affairs Nebraska Western Iowa Health Care System, Research Service (151), 4101 Woolworth Avenue, Omaha, Nebraska, 68105,United States
Keywords: Liver, alcohol, steatosis, lipid, triglycerides, adipose, lipid droplet, perilipin, phosphatidylcholine, phosphatidylethanolamine, lipases, ATGL, HSL, TGH, lipolysis, lipophagy, VLDL, rab, dynamin, Src, HCV, MiRs, betaine.
Abstract: For more than 30 years, lipid droplets (LDs) were considered as an inert bag of lipid for storage of energy-rich fat molecules. Following a paradigm shift almost a decade ago, LDs are presently considered an active subcellular organelle especially designed for assembling, storing and subsequently supplying lipids for generating energy and membrane synthesis (and in the case of hepatocytes for VLDL secretion). LDs also play a central role in many other cellular functions such as viral assembly and protein degradation. Here, we have explored the structural and functional changes that occur in hepatic and adipose tissue LDs following chronic ethanol consumption in relation to their role in the pathogenesis of alcoholic liver injury.
Export Options
About this article
Cite this article as:
Natarajan Kumar Sathish, Rasineni Karuna, Ganesan Murali, Feng Dan, McVicker L. Benita, McNiven A. Mark, Osna A. Natalia, Mott L. Justin, Casey A. Carol and Kharbanda K. Kusum*, Structure, Function and Metabolism of Hepatic and Adipose Tissue Lipid Droplets: Implications in Alcoholic Liver Disease, Current Molecular Pharmacology 2017; 10 (3) . https://dx.doi.org/10.2174/1874467208666150817111727
DOI https://dx.doi.org/10.2174/1874467208666150817111727 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)
Letters in Drug Design & Discovery Ricin and Saporin: Plant Enzymes for the Research and the Clinics
Current Chemical Biology Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease
CNS & Neurological Disorders - Drug Targets Peroxisomes, Peroxisomal Diseases, and the Hepatotoxicity Induced by Peroxisomal Metabolites
Current Drug Metabolism Chronic Cerebrospinal Venous Insufficiency (CCSVI) and Multiple Sclerosis (MS): A Critical Review
CNS & Neurological Disorders - Drug Targets Aetiology, Diagnosis and Treatment of Hydrops Foetalis
Current Pediatric Reviews Targeting Vesicle Trafficking: An Important Approach to Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery B Cells and Beyond: Therapeutic Opportunities Targeting Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Control and Role of Plateau Potential Properties in the Spinal Cord
Current Pharmaceutical Design Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
Current Medicinal Chemistry Multiple Protective Functions of Sigma1 Receptor
Current Protein & Peptide Science Engineered E. coli as Vehicles for Targeted Therapeutics
Current Gene Therapy The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease
Current Pharmaceutical Design Radial Approach for Percutaneous Coronary Intervention
Reviews on Recent Clinical Trials Stem Cell Therapies for the Lysosomal Storage Diseases – the Quintessential Neurodegenerative Diseases
Current Stem Cell Research & Therapy Compartmentalized Platforms for Neuro-Pharmacological Research
Current Neuropharmacology Platelets and Platelet-Derived Microvesicles as Immune Effectors in Type 2 Diabetes
Current Vascular Pharmacology Neurotoxicity of Ecstasy (MDMA): An Overview
Current Pharmaceutical Biotechnology Vascular Endothelial Primary Cilia: Mechanosensation and Hypertension
Current Hypertension Reviews Safety Profile of Plasmid/Liposomes and Virus Vectors in Clinical Gene Therapy
Current Drug Safety